搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Geobacillus sp. Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP509490GFJ
CSB-EP509490GFJ
CSB-BP509490GFJ
CSB-MP509490GFJ
CSB-EP509490GFJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacillus sp. Methylthioribose kinase (mtnK) CSB-YP509491GFJ
CSB-EP509491GFJ
CSB-BP509491GFJ
CSB-MP509491GFJ
CSB-EP509491GFJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacillus sp. UPF0180 protein GWCH70_0946 (GWCH70_0946) CSB-YP509492GFJ
CSB-EP509492GFJ
CSB-BP509492GFJ
CSB-MP509492GFJ
CSB-EP509492GFJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacillus sp. Ribosomal RNA small subunit methyltransferase H (rsmH) CSB-YP509493GFJ
CSB-EP509493GFJ
CSB-BP509493GFJ
CSB-MP509493GFJ
CSB-EP509493GFJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacillus sp. Dihydroorotate dehydrogenase B (NAD (+)), catalytic subunit CSB-YP509494GFJ
CSB-EP509494GFJ
CSB-BP509494GFJ
CSB-MP509494GFJ
CSB-EP509494GFJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacillus sp. UPF0122 protein GWCH70_1086 (GWCH70_1086) CSB-YP509495GFJ
CSB-EP509495GFJ
CSB-BP509495GFJ
CSB-MP509495GFJ
CSB-EP509495GFJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacillus sp. UPF0291 protein GWCH70_1239 (GWCH70_1239) CSB-YP509496GFJ
CSB-EP509496GFJ
CSB-BP509496GFJ
CSB-MP509496GFJ
CSB-EP509496GFJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacillus sp. 50S ribosomal protein L31 (rpmE) CSB-YP509497GFJ
CSB-EP509497GFJ
CSB-BP509497GFJ
CSB-MP509497GFJ
CSB-EP509497GFJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacillus sp. Adenylosuccinate synthetase (purA) CSB-YP509498GFJ
CSB-EP509498GFJ
CSB-BP509498GFJ
CSB-MP509498GFJ
CSB-EP509498GFJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacillus sp. Formimidoylglutamase (hutG) CSB-YP509499GFJ
CSB-EP509499GFJ
CSB-BP509499GFJ
CSB-MP509499GFJ
CSB-EP509499GFJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Geobacillus sp. Putative cobalt-precorrin-6A synthase [deacetylating] (cbiD) CSB-YP509500GFJ
CSB-EP509500GFJ
CSB-BP509500GFJ
CSB-MP509500GFJ
CSB-EP509500GFJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lachancea thermotolerans Altered inheritance of mitochondria protein 9, mitochondrial (AIM9), partial CSB-YP509501LMB
CSB-EP509501LMB
CSB-BP509501LMB
CSB-MP509501LMB
CSB-EP509501LMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lachancea thermotolerans Protein SWT21 (SWT21) CSB-YP509502LMB
CSB-EP509502LMB
CSB-BP509502LMB
CSB-MP509502LMB
CSB-EP509502LMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lachancea thermotolerans Altered inheritance of mitochondria protein 32 (AIM32) CSB-YP509503LMB
CSB-EP509503LMB
CSB-BP509503LMB
CSB-MP509503LMB
CSB-EP509503LMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lachancea thermotolerans Genetic interactor of prohibitins 3, mitochondrial (GEP3) CSB-YP509504LMB
CSB-EP509504LMB
CSB-BP509504LMB
CSB-MP509504LMB
CSB-EP509504LMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lachancea thermotolerans Altered inheritance of mitochondria protein 37, mitochondrial (AIM37) CSB-YP509505LMB
CSB-EP509505LMB
CSB-BP509505LMB
CSB-MP509505LMB
CSB-EP509505LMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lachancea thermotolerans Altered inheritance of mitochondria protein 4 (AIM4) CSB-YP509506LMB
CSB-EP509506LMB
CSB-BP509506LMB
CSB-MP509506LMB
CSB-EP509506LMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lachancea thermotolerans Restriction of telomere capping protein 1 (RTC1), partial CSB-YP509507LMB
CSB-EP509507LMB
CSB-BP509507LMB
CSB-MP509507LMB
CSB-EP509507LMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lachancea thermotolerans ATPase GET3 (GET3) CSB-YP509508LMB
CSB-EP509508LMB
CSB-BP509508LMB
CSB-MP509508LMB
CSB-EP509508LMB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lachancea thermotolerans Altered inheritance of mitochondria protein 31, mitochondrial (AIM31), partial CSB-YP509509LMB1
CSB-EP509509LMB1
CSB-BP509509LMB1
CSB-MP509509LMB1
CSB-EP509509LMB1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>